Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6459780rdf:typepubmed:Citationlld:pubmed
pubmed-article:6459780lifeskim:mentionsumls-concept:C2752508lld:lifeskim
pubmed-article:6459780lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:6459780lifeskim:mentionsumls-concept:C0005528lld:lifeskim
pubmed-article:6459780lifeskim:mentionsumls-concept:C1325604lld:lifeskim
pubmed-article:6459780lifeskim:mentionsumls-concept:C1167322lld:lifeskim
pubmed-article:6459780lifeskim:mentionsumls-concept:C0679823lld:lifeskim
pubmed-article:6459780lifeskim:mentionsumls-concept:C0812409lld:lifeskim
pubmed-article:6459780lifeskim:mentionsumls-concept:C0033727lld:lifeskim
pubmed-article:6459780pubmed:issue1lld:pubmed
pubmed-article:6459780pubmed:dateCreated1982-3-13lld:pubmed
pubmed-article:6459780pubmed:abstractTextDense granules, the storage organelles for 5-hydroxytryptamine in blood platelets, have been isolated from porcine platelets and are shown to transport 5-hydroxytryptamine in response to a transmembrane proton gradient (delta pH). Transport in the absence of delta pH is minimal, and it is shown that a rapid increase in transport takes place as delta pH increases. Direct measurements with [14C]methylamine show a delta pH of 1.1 units (acid inside) for intact granules. Osmotically active ghosts of dense granules from which 95% of the endogenous 5-hydroxytryptamine content has been released have also been prepared. Ghosts swell in the presence of ATP and Mg2+, and this swelling is shown to be due to the entry of protons via a process linked to ATP hydrolysis. Proton entry is also apparently linked to anion penetration in ghosts. Steady-state 5-hydroxytryptamine transport in ghosts is stimulated approx. 3-fold on the addition of ATP to the incubation medium, and the stimulation of 5-hydroxytryptamine transport in ghosts correlates with the formation of a transmembrane delta pH. Ghosts generate a delta pH of 1.1-1.3 pH units (acid inside) in the presence of 5 mM-ATP/2.5 mM-MgSO4. delta pH is generated within 3 min at 37 degrees C and is dissipated by the ionophore nigericin and by NH4Cl. It is shown that an Mg2+-stimulated ATPase activity is present on the ghost membrane, and inhibition of the ATPase leads to a corresponding decrease in 5-hydroxytryptamine transport. The results presented support the idea that 5-hydroxytryptamine transport into platelet dense granules is dependent on the presence of a transmembrane delta pH and, together with previous findings by others, suggest a generalized mechanism for biogenic amine transport into subcellular storage organelles.lld:pubmed
pubmed-article:6459780pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:languageenglld:pubmed
pubmed-article:6459780pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:citationSubsetIMlld:pubmed
pubmed-article:6459780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6459780pubmed:statusMEDLINElld:pubmed
pubmed-article:6459780pubmed:monthJullld:pubmed
pubmed-article:6459780pubmed:issn0264-6021lld:pubmed
pubmed-article:6459780pubmed:authorpubmed-author:SalganicoffLLlld:pubmed
pubmed-article:6459780pubmed:authorpubmed-author:WilkinsJ AJAlld:pubmed
pubmed-article:6459780pubmed:issnTypePrintlld:pubmed
pubmed-article:6459780pubmed:day15lld:pubmed
pubmed-article:6459780pubmed:volume198lld:pubmed
pubmed-article:6459780pubmed:ownerNLMlld:pubmed
pubmed-article:6459780pubmed:authorsCompleteYlld:pubmed
pubmed-article:6459780pubmed:pagination113-23lld:pubmed
pubmed-article:6459780pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:meshHeadingpubmed-meshheading:6459780-...lld:pubmed
pubmed-article:6459780pubmed:year1981lld:pubmed
pubmed-article:6459780pubmed:articleTitleParticipation of a transmembrane proton gradient in 5-hydroxytryptamine transport by platelet dense granules and dense-granule ghosts.lld:pubmed
pubmed-article:6459780pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6459780pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:6459780pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6459780lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6459780lld:pubmed